BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

WuXi Biologics Secures MFDS GMP Certification For Three Key Manufacturing Facilities

WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that three of its manufacturin...

April 24, 2026 | News

SynbioTech Probiotic Strain Shows Potential In Uric Acid Regulation Through Multi Mechanism Action

SynbioTech announced that its Lactiplantibacillus plantarum FS4722 (L. plantarum FS4722), a probiotic strain isolated from traditional Chine...

April 23, 2026 | News

ImmunoForge Advances CNS Drug Delivery With LMT15 Platform And Global Recognition

ImmunoForge's LMT15 Platform combines high BBB permeability with proprietary long-acting ELP technology Technology excellence validated by winning first...

April 23, 2026 | News

EpiBiologics Advances Tissue Selective EGFR Degrader EPI 326 Into First In Human Clinical Study

First-in-human study of EPI-326 will evaluate the company’s lead tissue-selective EGFR degrader in patients with NSCLC and HNSCC with potential to ...

April 21, 2026 | News

GC Biopharma Reports Proprietary Analytical Method For Precise Factor XI Measurement In Journal of Microbiology and Biotechnology

Proprietary analytical method for precise Factor XI (FXI) measurement published in the Journal of Microbiology and Biotechnology Novel IgG B...

April 07, 2026 | News

Samsung Biologics Completes Rockville Facility Acquisition To Expand U.S. Manufacturing Footprint

Adds 60,000 liters of drug substance capacity, bringing the total to 845,000 liters Marks Samsung Biologics' geographical diversification and establishe...

April 02, 2026 | News

Acurx Pharmaceuticals Secures Korean Patent To Strengthen DNA Polymerase IIIC Inhibitor Portfolio

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule...

March 31, 2026 | News

Neurophet Partners With ALZ NET To Advance AI Driven Imaging In Alzheimer’s Care

Aims to improve quality of care for patients with Alzheimer's disease… Exploring adoption of Neurophet's key solutions Collaboration expected to ...

March 31, 2026 | News

Biogen Secures Exclusive Rights To Develop Subcutaneous Biologics Using Alteogen’s ALT B4 Platform

Biogen gains rights to develop and commercialize subcutaneous (SC) formulations for two products utilizing ALT-B4 Alteogen Inc. (KOSDAQ: 196170) ann...

March 27, 2026 | News

GC Biopharma Secures First Latin America Approval For Antibiotic Free Varicella Vaccine

First regulatory clearance in Latin America marks a strategic milestone for regional market expansion- World's first antibiotic-free manufacturing process ...

March 27, 2026 | News

GI Innovation Enters Clinical Supply Agreement With Johnson And Johnson To Advance Prostate Cancer Combination Therapy

GI Innovation announced on 19th that it has entered into a clinical supply agreement with Johnson & Johnson to evaluate a combination therapy...

March 23, 2026 | News

DNA Script Expands Global Reach Of SYNTAX Platform Through Strategic Distribution Partnerships

DNA Script, a pioneer in DNA synthesis providing scientists with rapid, on-demand access to high-quality DNA, announced it has signed distribution ag...

March 19, 2026 | News

Samsung Bioepis And Sandoz Expand Global Biosimilar Alliance Across Five Assets

The agreement covers up to five assets, including SB36, a biosimilar candidate referencing Entyvio (vedolizumab), for collaboration of development and ...

March 18, 2026 | News

Celltrion Expands US Immunology Portfolio With AVTOZMA Subcutaneous Tocilizumab Biosimilar

AVTOZMA® (tocilizumab-anoh) is among the first wave of tocilizumab biosimilars with both intravenous (IV) and subcutaneous (SC) formulations app...

March 17, 2026 | News

Stay Connected